AI's Potential in Pharma Manufacturing Roundtable

March 13, 2025
2:00 PM ET / 1:00 PM CT / 11:00 AM PT / 7:00 PM GMT

Duration: 1 hour
Already registered? Click here to log in. 

Summary

New AI technologies hold tremendous potential for use in all areas of the pharma industry, but as the industry ventures into this uncharted territory, new regulatory considerations must be addressed. FDA Commission Robert Califf has communicated a desire to get ahead of regulating new disruptive technology and most anticipate that regulators will adopt a cautious yet risk-based approach. This webinar will explore how pharma companies can navigate this evolving regulatory landscape in order to make the most of AI technologies.